Cargando…
Ocular neuroprotection by siRNA targeting caspase-2
Retinal ganglion cell (RGC) loss after optic nerve damage is a hallmark of certain human ophthalmic diseases including ischemic optic neuropathy (ION) and glaucoma. In a rat model of optic nerve transection, in which 80% of RGCs are eliminated within 14 days, caspase-2 was found to be expressed and...
Autores principales: | Ahmed, Z, Kalinski, H, Berry, M, Almasieh, M, Ashush, H, Slager, N, Brafman, A, Spivak, I, Prasad, N, Mett, I, Shalom, E, Alpert, E, Di Polo, A, Feinstein, E, Logan, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168996/ https://www.ncbi.nlm.nih.gov/pubmed/21677688 http://dx.doi.org/10.1038/cddis.2011.54 |
Ejemplares similares
-
Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors
por: Almasieh, M, et al.
Publicado: (2010) -
Effects of intravitreal injection of siRNA against caspase-2 on retinal and optic nerve degeneration in air blast induced ocular trauma
por: Thomas, Chloe N., et al.
Publicado: (2021) -
Tau and Caspase 3 as Targets for Neuroprotection
por: Idan-Feldman, Anat, et al.
Publicado: (2012) -
Molecular Umbrella Conjugate for the Ocular Delivery
of siRNA
por: Janout, Vaclav, et al.
Publicado: (2014) -
The neuroprotective effect of nicotine in Parkinson’s disease models is associated with inhibiting PARP-1 and caspase-3 cleavage
por: Lu, Justin Y.D., et al.
Publicado: (2017)